Author:
Yoshimasu Tatsuya,Sasaki Rie,Oura Shoji,Hirai Issei,Kokawa Yozo,Tanino Hirokazu,Sakurai Teruhisa,Okamura Yoshitaka
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference12 articles.
1. See WA, Cohen MB, Hoxie LD: Alpha-Fetoprotein half-life as a predictor of residual testicular tumor.Cancer 71:2048–2054,1993.
2. Pontes JE, Jabalameli P, Montie J, Foemmel R, Howard PD, Boyett J: Prognostic implications of disappearance rate of biologic markers following radical prostatectomy.Urology 36:415–419,1990.
3. Oesterling JE, Chan DW, Epstein JI, Kimball AW Jr, Bruzek DJ, Rock RC, Brendler CB, Walsh PC: Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.J Urol 139:766–772, 1988.
4. van Straalen JP, Bossens MM, de Reijke TM, Sanders GT: Biological half-life of prostate-specific antigen after radical prostatectomy.Eur J Clin Chem Clin Biochem 32:53–55,1994.
5. Verhelst J, Van den Broecke E, Van Meerbeeck J, De Backer W, Blockx P, Vermeire P: Calculation of half-life of carcinoembryonic antigen after lung tumour resection: a case report.Eur Respir J 4:374–376,1991.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The issues and challenges with cancer biomarkers;Journal of Cancer Research and Therapeutics;2023